World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7223)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

446

WORD

166

HTML

4213

Figures (1-4)

241

Tables (1-1)

220

Sum=5286

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

791

Download

1146

Sum=1937

Apr 28, 2020 (publication date) through Jun 5, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Vindum HH, Agnholt JS, Nielsen AWM, Nielsen MB, Schmidt H. Severe steroid refractory gastritis induced by Nivolumab: A case report. World J Gastroenterol 2020; 26(16): 1971-1978 [PMID: 32390707 DOI: 10.3748/wjg.v26.i16.1971]
URL:	https://www.wjgnet.com/1007-9327/full/v26/i16/1971.htm

Number	Citing Articles
1	Elena Cijauskaite, Edita Kazenaite, Sandra Strainiene, Goda Sadauskaite, Benediktas Kurlinkus. Nivolumab-induced tumour-like gastritis: A case report. World Journal of Clinical Cases 2023; 11(18): 4350-4359 doi: 10.12998/wjcc.v11.i18.4350 Abstract(311) \| Core Tip(162) \| Full Article(HTML)(1068) \| Full Article with Cover (PDF)-4784K(52) \| Full Article (Word)-3479K(21) \| Audio-552K(0) \| Peer-Review Report-369K(18) \| Answering Reviewers-61K(16) \| Supplementary Material-336K(21) \| Full Article (PDF)-4586K(101) \| Full Article (XML)-83K(24) \| Times Cited (3) \| Total Visits (2850) \| Open
2	Jing Lin, Zhong-Qiao Lin, Shi-Cheng Zheng, Yu Chen. Immune checkpoint inhibitor-associated gastritis: Patterns and management. World Journal of Gastroenterology 2024; 30(14): 1941-1948 doi: 10.3748/wjg.v30.i14.1941 Abstract(97) \| Core Tip(95) \| Full Article(HTML)(1011) \| Full Article with Cover (PDF)-709K(25) \| Audio-1549K(3) \| Peer-Review Report-220K(21) \| Answering Reviewers-149K(15) \| Full Article (PDF)-413K(52) \| Full Article (XML)-160K(11) \| Times Cited (0) \| Total Visits (1846) \| Open
3	Keita Saito, Daiki Ozono, Hironobu Nagumo, Masayo Yoshimura, Yoko Masuzawa. Temporal observation of endoscopic and histological findings of gastritis after administration of an immune checkpoint inhibitor: a case report. Clinical Journal of Gastroenterology 2022; 15(2): 368 doi: 10.1007/s12328-021-01582-5
4	Vishnupriyadevi Parvathareddy, Umut Selamet, Aditi A. Sen, Omar Mamlouk, Juhee Song, Valda D. Page, Maen Abdelrahim, Adi Diab, Noha Abdel-Wahab, Ala Abudayyeh. Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor Response. Cancers 2023; 15(21): 5181 doi: 10.3390/cancers15215181
5	Satomi Omotehara, Mutsumi Nishida, Kana Yamanashi, Kensuke Sakurai, Takehiko Katsurada, Yoshito Komatsu, Ai Shimizu, Hitoshi Shibuya, Naofumi Shinagawa, Junichi Sugita, Takanori Teshima. A case of immune checkpoint inhibitor‐associated gastroenteritis detected by ultrasonography. Journal of Clinical Ultrasound 2021; 49(6): 605 doi: 10.1002/jcu.22975
6	Asunción Ojeda Gómez, Maria Isabel Pamies Ramón, Alicia Brotons Brotons, Nuria Jiménez García, Maria Dolores Picó Sala, María Cabezas Macian, Javier Sola Vera Sánchez, Mariana Fe García Sepulcre. Nivolumab-induced acute neutrophilic gastritis: Case report in a tertiary hospital. Gastroenterología y Hepatología 2024; 47(1): 74 doi: 10.1016/j.gastrohep.2023.01.006
7	Yuya Sugiyama, Hiroki Tanabe, Taisuke Matsuya, Yu Kobayashi, Yuki Murakami, Takahiro Sasaki, Takehito Kunogi, Keitaro Takahashi, Katsuyoshi Ando, Nobuhiro Ueno, Shin Kashima, Kentaro Moriichi, Mishie Tanino, Yusuke Mizukami, Mikihiro Fujiya, Toshikatsu Okumura. Severe immune checkpoint inhibitor-associated gastritis: A case series and literature review. Endoscopy International Open 2022; 10(07): E982 doi: 10.1055/a-1839-4303
8	George Samonis, Aikaterini Bousmpoukea, Aristea Molfeta, Antonios D. Kalkinis, Kalliopi Petraki, Christos Koutserimpas, Dimitrios Bafaloukos. Severe Gastritis Due to Nivolumab Treatment of a Metastatic Melanoma Patient. Diagnostics 2022; 12(11): 2864 doi: 10.3390/diagnostics12112864
9	Aneesha Haryal, Matthew J. Townsend, Vinitha Baskaran, Padmavathi Srivoleti, Anita Giobbie‐Hurder, Jordan S. Sack, Raymond A. Isidro, Nicole R. LeBoeuf, Elizabeth I. Buchbinder, F. Stephen Hodi, Shilpa Grover. Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course. Cancer 2023; 129(3): 367 doi: 10.1002/cncr.34543
10	Faisal Fa'ak, Maryam Buni, Adewunmi Falohun, Huifang Lu, Juhee Song, Daniel H Johnson, Chrystia M Zobniw, Van A Trinh, Muhammad Osama Awiwi, Nourel Hoda Tahon, Khaled M Elsayes, Kaysia Ludford, Emma J Montazari, Julia Chernis, Maya Dimitrova, Sabina Sandigursky, Jeffrey A Sparks, Osama Abu-Shawer, Osama Rahma, Uma Thanarajasingam, Ashley M Zeman, Rafee Talukder, Namrata Singh, Sarah H Chung, Petros Grivas, May Daher, Ala Abudayyeh, Iman Osman, Jeffrey Weber, Jean H Tayar, Maria E Suarez-Almazor, Noha Abdel-Wahab, Adi Diab. Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events. Journal for ImmunoTherapy of Cancer 2023; 11(6): e006814 doi: 10.1136/jitc-2023-006814
11	Matthew J. Townsend, Isaac J. Benque, Michael Li, Shilpa Grover. Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors. Alimentary Pharmacology & Therapeutics 2024; 59(11): 1350 doi: 10.1111/apt.17980
12	Daniel J. Hughes, Manil Subesinghe, Benjamin Taylor, Andrea Bille, James Spicer, Sophie Papa, Vicky Goh, Gary J. R. Cook. 18F FDG PET/CT and Novel Molecular Imaging for Directing Immunotherapy in Cancer. Radiology 2022; 304(2): 246 doi: 10.1148/radiol.212481
13	Iulianna Taritsa, Jennifer N. Choi. Immune Checkpoint Inhibitors and Systemic Side Effects: Overview for the Inpatient Dermatologist. Current Dermatology Reports 2023; 12(4): 225 doi: 10.1007/s13671-023-00415-7
14	Miho Sakai, Yuki Haga, Michiyo Kambe, Koji Nishimura, Ayako Shingyouchi, Tatsuo Miyamura, Kenji Ito, Asami Abe, Satoru Kaneda, Minoru Tada, Masaaki Saito, Nobuyuki Sugiura. A case of immune-related adverse effect diffuse gastritis induced by nivolumab. Progress of Digestive Endoscopy 2021; 98(1): 91 doi: 10.11641/pde.98.1_91
15	Nivolumab. Reactions Weekly 2020; 1817(1): 250 doi: 10.1007/s40278-020-82209-y
16	Jan-Malte Placke, Josefine Rawitzer, Henning Reis, Jassin Rashidi-Alavijeh, Elisabeth Livingstone, Selma Ugurel, Eva Hadaschik, Klaus Griewank, Kurt Werner Schmid, Dirk Schadendorf, Alexander Roesch, Lisa Zimmer. Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition – Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 Immunohistochemistry. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.725549
17	Asunción Ojeda Gómez, Maria Isabel Pamies Ramón, Alicia Brotons Brotons, Nuria Jiménez García, Maria Dolores Picó Sala, María Cabezas Macian, Javier Sola Vera Sánchez, Mariana Fe García Sepulcre. Nivolumab-induced acute neutrophilic gastritis: Case report in a tertiary hospital. Gastroenterología y Hepatología (English Edition) 2024; 47(1): 74 doi: 10.1016/j.gastre.2023.01.012